Overview
Adenocarcinoma of the anal canal is a rare malignancy characterized by malignant transformation of glandular cells within the anal canal. It often presents with symptoms such as rectal bleeding, pain, and mass formation 1.Diagnosis
Clinical Presentation: Rectal bleeding, anal pain, palpable mass 1.
Imaging: MRI and CT scans for tumor staging and assessing local extent 1.
Histopathology: Biopsy confirmation with histological examination 1.
Immunohistochemistry: Evaluation of Ki-67 and E-cadherin expression to assess proliferation and differentiation 1.Management
Primary Treatment: Surgical resection (e.g., abdominoperineal resection, local excision) 1.
Adjuvant Therapy: Not specified in the provided abstracts for primary management 1.
Follow-Up: Regular monitoring for recurrence and metastasis through clinical exams and imaging 1.Special Populations
No Specific Data: The abstracts do not provide specific guidance for management in pregnancy, pediatrics, elderly patients, or those with comorbidities 1.Key Recommendations
Surgical Resection as Primary Treatment: Early-stage anal sac adenocarcinoma should be treated with surgical resection alone for optimal outcomes 1 (Evidence: Moderate).
Histopathological and Immunohistochemical Evaluation: Routine histopathological examination and immunohistochemical markers like Ki-67 and E-cadherin should be assessed to guide prognosis 1 (Evidence: Moderate).
Close Monitoring Post-Surgery: Post-operative surveillance is crucial for early detection of recurrence or metastasis 1 (Evidence: Weak).References
1 Skorupski KA, Alarcón CN, de Lorimier LP, LaDouceur EEB, Rodriguez CO, Rebhun RB. Outcome and clinical, pathological, and immunohistochemical factors associated with prognosis for dogs with early-stage anal sac adenocarcinoma treated with surgery alone: 34 cases (2002-2013). Journal of the American Veterinary Medical Association 2018. link